Patents Examined by Jezia Riley
  • Patent number: 11345950
    Abstract: Activity-based probes that can be used to selectively identify and characterize enzymes that are involved in different phases of xenobiotic metabolism in a host and its microbiota population(s) are described. The activity-based probes described specifically label only their target active enzymes involved in xenobiotic metabolism and therefore provide a measurement of true protein functional activity rather than transcript or protein abundance. The activity-based probes also provide multimodal profiling of these active enzymes. Methods for preparing the activity based probes and exemplary methods for their use also are disclosed.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: May 31, 2022
    Assignee: Battelle Memorial Institute
    Inventors: Aaron T. Wright, Susan Ramos-Hunter, Christopher Whidbey
  • Patent number: 11345961
    Abstract: Embodiments may include a method of determining a nucleic acid sequence. The nucleic acid may be DNA. The method may include forming, by a polymerase, a double-stranded nucleic acid molecule from a first nucleic acid strand and a second nucleic acid strand. Forming the double-stranded nucleic acid molecule may include adding a first compound to the second nucleic acid strand. The first compound may include a nucleotide attached to a third nucleic acid strand. The third nucleic acid strand may be attached to a moiety. The method may also include detaching the nucleotide from the third nucleic acid strand and the moiety. The method may further include measuring a change in an electrical characteristic of a transistor resulting from the moiety. Additionally, the method may include identifying the nucleotide based on the measured change in the electrical characteristic.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: May 31, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: Yann Astier
  • Patent number: 11331643
    Abstract: The invention provides improved methods for synthesizing polynucleotides, such as DNA and RNA, using renewable initiators coupled to a solid support. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 17, 2022
    Assignee: Molecular Assemblies, Inc.
    Inventors: J. William Efcavitch, Matthew T. Holden
  • Patent number: 11326203
    Abstract: The disclosure provides methods for sequencing nucleic acids using, including with nucleotide analogs and subsequently appended labels.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: May 10, 2022
    Assignee: Ultima Genomics, Inc.
    Inventors: Linda Lee, Steven Menchen, Theo Nikiforov, Gilad Almogy, Florian Oberstrass
  • Patent number: 11319349
    Abstract: Described herein are recognition modules that bind specifically to a template nucleic acid and which ligate together in a reducing environment to produce a gamma peptide nucleic acid (?PNA) oligomer. Also provided are methods of synthesizing a ?PNA oligomer on a template using the recognition modules.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: May 3, 2022
    Assignee: Carnegie Mellon University
    Inventors: Danith H. Ly, Raman Bahal, Dinesh Chandra Bhunia, Yidan Cong, Arunava Manna, Srinivas Rapireddy
  • Patent number: 11306074
    Abstract: The present disclosure relates to a composition for analysis of DNA sequences and a method for analysis of DNA sequences by using the same and, more particularly, to a composition comprising the compound represented by Chemical Formula 1 and a method for analysis of DNA sequences, the method comprising a step of treating a sample with the same. The compound represented by Chemical Formula 1 in which TAMRA is linked to polypyrrole specifically binds an A/T base pair (W) to fluoresce alone without causing DNA photocleavage. Therefore, the compound is useful for DNA analysis particularly at the single DNA molecule level.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: April 19, 2022
    Assignee: Sogang University Research Foundation
    Inventors: Kyu Bong Jo, Seong Hyun Lee, Hiroshi Sugiyama
  • Patent number: 11299511
    Abstract: The present disclosure provides a solid phase method of making oligonucleotides via sequential coupling cycles including at least one coupling of a dinucleotide dimer subunit to a free 3?-terminal group of a growing chain. The oligonucleotides include at least two nucleoside subunits joined by a N3??P5? phosphoramidate linkage. The method may include the steps of (a) deprotecting the protected 3? amino group of a terminal nucleoside attached to a solid phase support, said deprotecting forming a free 3? amino group; (b) contacting the free 3? amino group with a 3?-protected amino-dinucleotide-5?-phosphoramidite dimer in the presence of a nucleophilic catalyst to form an internucleoside N3??P5? phosphoramidite linkage; and (c) oxidizing (e.g., sulfurizing) the linkage. The compositions produced by the subject methods may include a reduced amount of one or more (N?x) oligonucleotide products. Also provided are pharmaceutical compositions including the subject oligonucleotide compositions.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: April 12, 2022
    Assignee: Geron Corporation
    Inventor: Premchandran H. Ramiya
  • Patent number: 11293060
    Abstract: The present invention relates to improving the processing rate of a sequencing reaction, for example in a nanopore sequencing reaction, by means of using improved nucleoside-tags. The tags are linked to the nucleoside phosphate via a Pictet Spengler reaction. Exemplary sequencing reactions that are improved by the present methods include nanopore-based nucleic acid sequencing-by-synthesis reactions.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: April 5, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Ian Quang Chau, Peter Crisalli, Hannah Marie Kallewaard-Lum, Hannes Kuchelmeister, Sebastian Johannes Pomplun, Hasham Saqib, Christian Wellner
  • Patent number: 11293061
    Abstract: Embodiments of the present disclosure relate to sequencing methods using nucleotide molecules with a 3? AOM blocking group, which can provide reduced phasing and pre-phasing values. Also provided herein are kits related to such sequencing methods.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: April 5, 2022
    Assignee: Illumina Cambridge Limited
    Inventors: Antoine Francais, Elena Cressina, Adam Culley, Angelica Mariani, Xiaolin Wu, Xiaohai Liu
  • Patent number: 11293050
    Abstract: Disclosed are a method for marking 5-formyl cytosine and the use thereof in single base resolution sequencing. The method for marking the 5-formyl cytosine comprises the following steps of: (1) preparing a DNA or RNA sample; and (2) mixing the DNA or RNA sample with a buffer solution and a compound R1—CH2—CN to obtain a marking reaction system; and reacting the compound R1—CH2—CN therein with the 5-formyl cytosine in DNA and RNA molecules, and thereby achieving the marking of the 5-formyl cytosine; the reaction process is as in (I) below: wherein, R1 is an electron withdrawing group next to the CH2 group, preferably —CN, (II) or (III), and more preferably —CN; R is a DNA or RNA molecule connected to the 5-formyl cytosine; and the pH value of the marking reaction system is 7.5-9. On this basis, also provided in the present invention is a sequencing analysis method for the 5-formyl cytosine.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: April 5, 2022
    Assignee: Peking University
    Inventors: Chengqi Yi, Chenxu Zhu, Bo Xia
  • Patent number: 11287422
    Abstract: Multivalent binding compositions including a particle-nucleotide conjugate having a plurality of copies of a nucleotide attached to the particle are described. The multivalent binding compositions allow one to localize detectable signals to active regions of biochemical interaction, e.g., sites of protein-protein interaction, protein-nucleic acid interaction, nucleic acid hybridization, or enzymatic reaction, and can be used to identify sites of base incorporation in elongating nucleic acid chains during polymerase reactions and to provide improved base discrimination for sequencing and array based applications.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: March 29, 2022
    Assignee: ELEMENT BIOSCIENCES, INC.
    Inventors: Michael Previte, Molly Min He, Junhua Zhao, Hui Zhen Mah, Chunhong Zhou, Sinan Arslan, Matthew Kellinger, Lorenzo Berti, Steve Xiangling Chen
  • Patent number: 11279736
    Abstract: The present invention relates to ?-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: March 22, 2022
    Assignee: CARNEGIE MELLON UNIVERSITY
    Inventors: Danith H. Ly, Srinivas Rapireddy, Bichismita Sahu
  • Patent number: 11274337
    Abstract: Emulsion compositions are provided herein. Also provided herein are kits containing one or more emulsion compositions or components for making such emulsion compositions. Also provided herein are methods of using such emulsion compositions, such as for amplification of target nucleic acids in emulsion droplets.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: March 15, 2022
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Yi Xue, Joshua Ritchey, Robert Meltzer
  • Patent number: 11268099
    Abstract: The invention relates to an oligonucleotide including one or more modified nucleoside bases having the structure -B-L-A wherein for each of the modified nucleosides A is independently a monosaccharide or oligosaccharide, Lisa linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide; and wherein the oligonucleotide binds specifically to a carbohydrate-binding monoclonal antibody with an affinity of less than 100 nM. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are disclosed, including inducing an immune response, inhibiting viral or bacterial infection, treating a cancerous condition, and detecting a neutralizing antibody.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: March 8, 2022
    Assignee: BRANDEIS UNIVERSITY
    Inventor: Isaac J. Krauss
  • Patent number: 11267842
    Abstract: There are provided, inter alia, methods and reagents for labeling nucleic acids.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: March 8, 2022
    Assignee: The Regents of the University of California
    Inventors: Neal K. Devaraj, Seth C. Alexander
  • Patent number: 11267979
    Abstract: Fluorescent dyes, ink compositions comprising the dyes, methods and devices for printing the ink compositions, images printed using the ink compositions and methods for authenticating the printed images are provided. The fluorescent dyes are heterorotaxanes that include large macrocyclic rings around fluorophores and are capable of emitting solid-state fluorescence. When the heterorotaxanes are combined with encapsulating agents and competitive binding agents in aqueous solution, the resulting ink composition exhibits a complex, dynamic equilibrium that provides a tunable fluorescence emission spectrum with a non-linear response to the dye concentration.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: March 8, 2022
    Assignees: Northwestern University, Innotune LLC
    Inventors: James Fraser Stoddart, Xisen Hou, Chenfeng Ke, Roger B. Pettman
  • Patent number: 11266673
    Abstract: Disclosed herein, inter alia, are compounds, compositions, and methods of use thereof in the sequencing a nucleic acid.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: March 8, 2022
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Jingyue Ju, Xin Chen, Xiaoxu Li, Zengmin Li, Min-Kang Hsieh, Minchen Chien, Shundi Shi, Jianyi Ren, Cheng Guo, Shiv Kumar, James J. Russo, Chuanjuan Tao, Steffen Jockusch, Sergey Kalachikov
  • Patent number: 11261480
    Abstract: A method for processing a nucleic acid, in which the nucleic acid is exposed to an aqueous medium which includes a polyol in sufficient proportion for at least a portion of the nucleic acid to enter or remain in an extra-solution phase. Thus, a polyol may be used to bind a nucleic acid which is in solution to a solid support or to wash a nucleic acid on a solid support whilst maintaining it on the support. The polyol may for example be a C2-C10 alkanediol.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: March 1, 2022
    Assignee: Life Technologies AS
    Inventors: Darren Ellis, Geir Fonnum, Nini Kjus
  • Patent number: 11249086
    Abstract: The present invention provides, among other aspects, functionalized chromophoric polymer dots comprising a hydrophobic core and a hydrophilic cap, and bioconjugates thereof. Also provided are improved methods for preparing functionalized chromophoric polymer dots. Methods for in vivo imaging and molecular labeling are also disclosed.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: February 15, 2022
    Assignee: UNIVERSITY OF WASHINGTON
    Inventors: Daniel T. Chiu, Changfeng Wu, Jason McNeill, Jiangbo Yu
  • Patent number: 11242561
    Abstract: This invention provides a process for sequencing nucleic acids using 3? modified deoxynucleotide analogues or 3? modified deoxyinosine triphosphate analogues, and 3? modified dideoxynucleotide analogues having a detectable marker attached thereto.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: February 8, 2022
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Jingyue Ju, Dae Hyun Kim, Jia Guo, Qinglin Meng, Zengmin Li, Huanyan Cao